Use of R(+) -α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disorders
First Claim
Patent Images
1. A method of treating a patient for a sleep disorder by administering to the patient a therapeutically effective amount of R-(+)-α
- -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.
3 Assignments
0 Petitions
Accused Products
Abstract
A method of treating a patient for a Sleep Disorder comprising administering an effective amount of R-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
-
Citations
25 Claims
-
1. A method of treating a patient for a sleep disorder by administering to the patient a therapeutically effective amount of R-(+)-α
- -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (2, 3, 4)
-
5. A monotherapeutic method of treating a patient for a sleep disorder and a condition selected from the group consisting of schizophrenia, fibromyalgia, obsessive compulsive disorder, coronary vasospasm, thrombotic illness, angina, anorexia nervosa, Raynaud'"'"'s phenomenon, extrapyramidal symptoms, anxiety, arrhythmia and bipolar depression, comprising administering to the patient in need of said method a therapeutically effective amount of R-(+)-α
- -(2,3-dimethoxyphenyl)1-[2-(4-fluorophenyl)ethyl ]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
Specification